Unmasking silent neurotoxicity following developmental exposure to environmental toxicants

Andrew D. Kraft, Michael Aschner, Deborah A. Cory-Slechta, Staci D. Bilbo, W. Michael Caudle, Susan L. Makris

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Silent neurotoxicity, a term introduced approximately 25 years ago, is defined as a persistent change to the nervous system that does not manifest as overt evidence of toxicity (i.e. it remains clinically unapparent) unless unmasked by experimental or natural processes. Silent neurotoxicants can be challenging for risk assessors, as the multifactorial experiments needed to reveal their effects are seldom conducted, and they are not addressed by current study design guidelines. This topic was the focus of a symposium addressing the interpretation and use of silent neurotoxicity data in human health risk assessments of environmental toxicants at the annual meeting of the Developmental Neurotoxicology Society (previously the Neurobehavioral Teratology Society) on June 30th, 2014. Several factors important to the design and interpretation of studies assessing the potential for silent neurotoxicity were discussed by the panelists and audience members. Silent neurotoxicity was demonstrated to be highly specific to the characteristics of the animals being examined, the unmasking agent tested, and the behavioral endpoint(s) evaluated. Overall, the experimental examples presented highlighted a need to consider common adverse outcomes and common biological targets for chemical and non-chemical stressors, particularly when the exposure and stressors are known to co-occur. Risk assessors could improve the evaluation of silent neurotoxicants in assessments through specific steps from researchers, including experiments to reveal the molecular targets and mechanisms that may result in specific types of silent neurotoxicity, and experiments with complex challenges reminiscent of the human situation.

Original languageEnglish (US)
Pages (from-to)38-44
Number of pages7
JournalNeurotoxicology and Teratology
Volume55
DOIs
StatePublished - May 1 2016

Fingerprint

Environmental Exposure
Nervous System
Health risks
Experiments
Research Personnel
Neurology
Guidelines
Risk assessment
Toxicity
Health
Animals

Keywords

  • Behavior
  • Delayed-onset
  • Development
  • Environmental health
  • Neurotoxicity
  • Risk assessment

ASJC Scopus subject areas

  • Developmental Neuroscience
  • Cellular and Molecular Neuroscience
  • Toxicology

Cite this

Unmasking silent neurotoxicity following developmental exposure to environmental toxicants. / Kraft, Andrew D.; Aschner, Michael; Cory-Slechta, Deborah A.; Bilbo, Staci D.; Caudle, W. Michael; Makris, Susan L.

In: Neurotoxicology and Teratology, Vol. 55, 01.05.2016, p. 38-44.

Research output: Contribution to journalArticle

Kraft, Andrew D. ; Aschner, Michael ; Cory-Slechta, Deborah A. ; Bilbo, Staci D. ; Caudle, W. Michael ; Makris, Susan L. / Unmasking silent neurotoxicity following developmental exposure to environmental toxicants. In: Neurotoxicology and Teratology. 2016 ; Vol. 55. pp. 38-44.
@article{76dc2305aa1f4e38983731433d4b760e,
title = "Unmasking silent neurotoxicity following developmental exposure to environmental toxicants",
abstract = "Silent neurotoxicity, a term introduced approximately 25 years ago, is defined as a persistent change to the nervous system that does not manifest as overt evidence of toxicity (i.e. it remains clinically unapparent) unless unmasked by experimental or natural processes. Silent neurotoxicants can be challenging for risk assessors, as the multifactorial experiments needed to reveal their effects are seldom conducted, and they are not addressed by current study design guidelines. This topic was the focus of a symposium addressing the interpretation and use of silent neurotoxicity data in human health risk assessments of environmental toxicants at the annual meeting of the Developmental Neurotoxicology Society (previously the Neurobehavioral Teratology Society) on June 30th, 2014. Several factors important to the design and interpretation of studies assessing the potential for silent neurotoxicity were discussed by the panelists and audience members. Silent neurotoxicity was demonstrated to be highly specific to the characteristics of the animals being examined, the unmasking agent tested, and the behavioral endpoint(s) evaluated. Overall, the experimental examples presented highlighted a need to consider common adverse outcomes and common biological targets for chemical and non-chemical stressors, particularly when the exposure and stressors are known to co-occur. Risk assessors could improve the evaluation of silent neurotoxicants in assessments through specific steps from researchers, including experiments to reveal the molecular targets and mechanisms that may result in specific types of silent neurotoxicity, and experiments with complex challenges reminiscent of the human situation.",
keywords = "Behavior, Delayed-onset, Development, Environmental health, Neurotoxicity, Risk assessment",
author = "Kraft, {Andrew D.} and Michael Aschner and Cory-Slechta, {Deborah A.} and Bilbo, {Staci D.} and Caudle, {W. Michael} and Makris, {Susan L.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ntt.2016.03.005",
language = "English (US)",
volume = "55",
pages = "38--44",
journal = "Neurotoxicology and Teratology",
issn = "0892-0362",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Unmasking silent neurotoxicity following developmental exposure to environmental toxicants

AU - Kraft, Andrew D.

AU - Aschner, Michael

AU - Cory-Slechta, Deborah A.

AU - Bilbo, Staci D.

AU - Caudle, W. Michael

AU - Makris, Susan L.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Silent neurotoxicity, a term introduced approximately 25 years ago, is defined as a persistent change to the nervous system that does not manifest as overt evidence of toxicity (i.e. it remains clinically unapparent) unless unmasked by experimental or natural processes. Silent neurotoxicants can be challenging for risk assessors, as the multifactorial experiments needed to reveal their effects are seldom conducted, and they are not addressed by current study design guidelines. This topic was the focus of a symposium addressing the interpretation and use of silent neurotoxicity data in human health risk assessments of environmental toxicants at the annual meeting of the Developmental Neurotoxicology Society (previously the Neurobehavioral Teratology Society) on June 30th, 2014. Several factors important to the design and interpretation of studies assessing the potential for silent neurotoxicity were discussed by the panelists and audience members. Silent neurotoxicity was demonstrated to be highly specific to the characteristics of the animals being examined, the unmasking agent tested, and the behavioral endpoint(s) evaluated. Overall, the experimental examples presented highlighted a need to consider common adverse outcomes and common biological targets for chemical and non-chemical stressors, particularly when the exposure and stressors are known to co-occur. Risk assessors could improve the evaluation of silent neurotoxicants in assessments through specific steps from researchers, including experiments to reveal the molecular targets and mechanisms that may result in specific types of silent neurotoxicity, and experiments with complex challenges reminiscent of the human situation.

AB - Silent neurotoxicity, a term introduced approximately 25 years ago, is defined as a persistent change to the nervous system that does not manifest as overt evidence of toxicity (i.e. it remains clinically unapparent) unless unmasked by experimental or natural processes. Silent neurotoxicants can be challenging for risk assessors, as the multifactorial experiments needed to reveal their effects are seldom conducted, and they are not addressed by current study design guidelines. This topic was the focus of a symposium addressing the interpretation and use of silent neurotoxicity data in human health risk assessments of environmental toxicants at the annual meeting of the Developmental Neurotoxicology Society (previously the Neurobehavioral Teratology Society) on June 30th, 2014. Several factors important to the design and interpretation of studies assessing the potential for silent neurotoxicity were discussed by the panelists and audience members. Silent neurotoxicity was demonstrated to be highly specific to the characteristics of the animals being examined, the unmasking agent tested, and the behavioral endpoint(s) evaluated. Overall, the experimental examples presented highlighted a need to consider common adverse outcomes and common biological targets for chemical and non-chemical stressors, particularly when the exposure and stressors are known to co-occur. Risk assessors could improve the evaluation of silent neurotoxicants in assessments through specific steps from researchers, including experiments to reveal the molecular targets and mechanisms that may result in specific types of silent neurotoxicity, and experiments with complex challenges reminiscent of the human situation.

KW - Behavior

KW - Delayed-onset

KW - Development

KW - Environmental health

KW - Neurotoxicity

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=84962467972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962467972&partnerID=8YFLogxK

U2 - 10.1016/j.ntt.2016.03.005

DO - 10.1016/j.ntt.2016.03.005

M3 - Article

C2 - 27049787

AN - SCOPUS:84962467972

VL - 55

SP - 38

EP - 44

JO - Neurotoxicology and Teratology

JF - Neurotoxicology and Teratology

SN - 0892-0362

ER -